nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation
|
Zhang, Jia-Min |
|
2019 |
442 |
C |
p. 193-201 |
artikel |
2 |
A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen
|
Lv, Qiaoying |
|
2019 |
442 |
C |
p. 137-147 |
artikel |
3 |
A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus
|
Fang, Jian |
|
2019 |
442 |
C |
p. 222-232 |
artikel |
4 |
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1
|
Namba, Masashi |
|
2019 |
442 |
C |
p. 31-39 |
artikel |
5 |
Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma
|
Koemans, Willem J. |
|
2019 |
442 |
C |
p. 279-286 |
artikel |
6 |
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
|
Tu, Mei-Juan |
|
2019 |
442 |
C |
p. 82-90 |
artikel |
7 |
Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3–p38 MAPK signalling
|
Wen, Siyang |
|
2019 |
442 |
C |
p. 320-332 |
artikel |
8 |
Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations
|
Loh, Amos H.P. |
|
2019 |
442 |
C |
p. 262-270 |
artikel |
9 |
Connexin 43 (Cx43) in cancer: Implications for therapeutic approaches via gap junctions
|
Bonacquisti, Emily E. |
|
2019 |
442 |
C |
p. 439-444 |
artikel |
10 |
DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC
|
Zhang, Lei |
|
2019 |
442 |
C |
p. 242-251 |
artikel |
11 |
Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α
|
Xu, An |
|
2019 |
442 |
C |
p. 40-52 |
artikel |
12 |
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression
|
Fürst, Katharina |
|
2019 |
442 |
C |
p. 299-309 |
artikel |
13 |
Editorial Board
|
|
|
2019 |
442 |
C |
p. ii |
artikel |
14 |
Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer
|
Tremble, Liam Friel |
|
2019 |
442 |
C |
p. 475-482 |
artikel |
15 |
Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations
|
Yu, Liqun |
|
2019 |
442 |
C |
p. 373-382 |
artikel |
16 |
Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression
|
Ding, Yixuan |
|
2019 |
442 |
C |
p. 351-361 |
artikel |
17 |
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
|
Chiu, Chien-Shan |
|
2019 |
442 |
C |
p. 113-125 |
artikel |
18 |
FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma
|
Li, Junjun |
|
2019 |
442 |
C |
p. 1-14 |
artikel |
19 |
Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer
|
Zhang, Panpan |
|
2019 |
442 |
C |
p. 53-67 |
artikel |
20 |
Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo
|
Xie, Xiaomeng |
|
2019 |
442 |
C |
p. 126-136 |
artikel |
21 |
HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells
|
Gupta, Parul |
|
2019 |
442 |
C |
p. 68-81 |
artikel |
22 |
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival
|
Yan, Han |
|
2019 |
442 |
C |
p. 333-340 |
artikel |
23 |
Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma
|
Choi, Seung Ah |
|
2019 |
442 |
C |
p. 161-169 |
artikel |
24 |
Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion
|
Cao, Mian-Fu |
|
2019 |
442 |
C |
p. 445-452 |
artikel |
25 |
Immunological therapy: A novel thriving area for triple-negative breast cancer treatment
|
Wang, Xiangyu |
|
2019 |
442 |
C |
p. 409-428 |
artikel |
26 |
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
|
De Vera, Albert A. |
|
2019 |
442 |
C |
p. 91-103 |
artikel |
27 |
Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity
|
Yu, Meiling |
|
2019 |
442 |
C |
p. 396-408 |
artikel |
28 |
Mechanosensitive TRPV4 channels stabilize VE-cadherin junctions to regulate tumor vascular integrity and metastasis
|
Cappelli, Holly C. |
|
2019 |
442 |
C |
p. 15-20 |
artikel |
29 |
Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma
|
Brummer, Christina |
|
2019 |
442 |
C |
p. 453-463 |
artikel |
30 |
Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells
|
Cetti, Elena |
|
2019 |
442 |
C |
p. 362-372 |
artikel |
31 |
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
|
De Veirman, Kim |
|
2019 |
442 |
C |
p. 233-241 |
artikel |
32 |
Nanotechnology-based photoimmunological therapies for cancer
|
Li, Yong |
|
2019 |
442 |
C |
p. 429-438 |
artikel |
33 |
NEO212, a conjugate of temozolomide and perillyl alcohol, blocks the endothelial-to-mesenchymal transition in tumor-associated brain endothelial cells in glioblastoma
|
Marín-Ramos, Nagore I. |
|
2019 |
442 |
C |
p. 170-180 |
artikel |
34 |
NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver
|
Deng, Qiaoting |
|
2019 |
442 |
C |
p. 21-30 |
artikel |
35 |
Oncofertility: What can we do from bench to bedside?
|
Zhao, Hua |
|
2019 |
442 |
C |
p. 148-160 |
artikel |
36 |
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts
|
Radhakrishnan, Rangasudhagar |
|
2019 |
442 |
C |
p. 464-474 |
artikel |
37 |
PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
|
Peng, Yang |
|
2019 |
442 |
C |
p. 181-192 |
artikel |
38 |
Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1
|
Huang, Wen-Tsung |
|
2019 |
442 |
C |
p. 287-298 |
artikel |
39 |
Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting
|
Appolloni, Irene |
|
2019 |
442 |
C |
p. 213-221 |
artikel |
40 |
Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer
|
Zhang, Yun-Kai |
|
2019 |
442 |
C |
p. 104-112 |
artikel |
41 |
RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism
|
Azatyan, Ani |
|
2019 |
442 |
C |
p. 341-350 |
artikel |
42 |
SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma
|
Song, Xianzhou |
|
2019 |
442 |
C |
p. 310-319 |
artikel |
43 |
Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen Enzalutamide sensitivity to better suppress the castration-resistant prostate cancer growth
|
Zhang, Meng |
|
2019 |
442 |
C |
p. 483-490 |
artikel |
44 |
The PEAK1–PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer
|
Ding, Chenbo |
|
2019 |
442 |
C |
p. 383-395 |
artikel |
45 |
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
|
Zhong, Li |
|
2019 |
442 |
C |
p. 252-261 |
artikel |
46 |
ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma
|
Li, Kai |
|
2019 |
442 |
C |
p. 271-278 |
artikel |
47 |
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers
|
Dai, Xinyu |
|
2019 |
442 |
C |
p. 202-212 |
artikel |